logo
Plus   Neg
Share
Email

Danaher Boosts Q4 Revenue Growth Outlook - Quick Facts

Ahead of President and Chief Executive Officer Rainer Blair commenting on the company's fourth quarter 2020 performance in a presentation at the J.P. Morgan Healthcare Conference later on Wednesday, Danaher Corp. (DHR) said Blair communicate that fourth quarter 2020 core revenue growth including Cytiva is expected to be above the Company's previously announced guidance, driven primarily by better performance in its Life Sciences and Diagnostics segments.

For the fourth quarter 2020, estimated revenues increased approximately 38.5% year-over-year, with approximately 15.0% estimated adjusted core revenue growth including Cytiva.

On average, analysts polled by Thomson Reuters expect the company to report revenue growth of 32.4 percent to $6.44 billion for the quarter.

The company had previously expected adjusted core revenue growth for the fourth quarter, including Cytiva, to be in the low-double digit range.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Metal Ware Corp. is recalling about 5,350 units of NESCO coffee bean roasters citing fire risk, the U.S. Consumer Product Safety Commission said in a statement. The recall involves Model CR-04-13 Coffee Bean Roasters with a date code of 2520 or 3220 printed at the bottom right of the ETL Intertek label on the product and on the box. Pfizer has uncovered the counterfeit versions of its Covid-19 vaccine in Mexico and Poland, according to a Wall Street Journal report. The vaccine was developed in partnership with Germany's BioNTech SE. Though there have been several reports of counterfeit versions of the Covid-19 vaccine, this seems to be the first confirmed instance. American Airlines is planning to resume hiring pilots this year to meet a rebound in travel demand in the summer season, reports said citing a company memo. The airline is expected to add 300 pilots by the end of the year and double that in 2022.
Follow RTT